Hot on the heels of winning Med-Tech Innovation’s special recognition award for its response to the COVID-19 pandemic by developing Q-POC, QuantuMDx has been developing a new assay that can detect up to four different respiratory diseases.
Ian Bolland, Acting Group Editor at Rapid News Group spoke to Jonathan O’Halloran, CEO of QuantuMDx about the latest assay developed by QuantuMDx as it aims to help battle flu season in the UK.
To read the full article, please visit: www.med-technews.com
Posted by:
Cure Talent